BPC-157 + TB-500 Blend 20mg
Body Protection Compound-157 (15-amino-acid pentadecapeptide)
CAS: 137525-51-0
10mg+10mg
Blended dose
One vial, two peptides
Canonical
Recovery stack
Research literature
BPC + TB
Complementary mechanisms
VEGFR2 + actin
Technical Data & References
Chemistry, identifiers, and primary literature for BPC-157 (Body Protection Compound-157) — available as lyophilized powder on Clav Tides.
- Short Sequence
- GEPPPGKPADDAGLV
- Full Sequence
- Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
- Salt Form
- Free acid (TFA removed)
- # Amino Acids
- 15
- Purity
- ≥98%
- Molecular Formula
- C62H98N16O22
- Molecular Weight
- 1419.53 g/mol
- CAS Number
- 137525-51-0
- PubChem CID
- 9941957
- Source
- Synthetic (partial sequence of human gastric juice protein BPC)
- Appearance
- Lyophilized powder
- Availability
- Lyophilized powder — Clav Tides
Primary Literature
- 1.
Sikiric P, Seiwerth S, Rucman R, et al. Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications. Curr Neuropharmacol. 2016;14(8):857-865.
DOI: 10.2174/1570159x13666160502153022 PMID: 27138887 PMC5333598
- 2.
Gwyer D, Wragg NM, Wilson SL. Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing. Cell Tissue Res. 2019 Aug;377(2):153-159.
- 3.
Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JH. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol. 2011 Mar;110(3):774-80.
Research use only. Data compiled from published literature and regulatory registries. BPC-157 + TB-500 Blend 20mg is supplied for in-vitro laboratory research — not for human consumption, injection, or therapeutic use.
Research peptide blend
Neither BPC-157 nor TB-500 are FDA-approved. Both remain in active research for injury recovery, tissue repair, and anti-inflammatory applications.
Pairs Well With
Also Known As
Mixing & Storage
BAC Water
4mL
Final Concentration
2.5 mg/mL of each peptide
Per Dose
250 μg/250 μg = 0.1 mL (10 IU)
One draw delivers both peptides; typical protocol 1–2× daily
Published References
- 1.Sikiric P, Seiwerth S, Rucman R, et al.. BPC 157 and standard angiogenic growth factors. Current Pharmaceutical Design (2018) PMID: 29745331
- 2.Goldstein AL, Hannappel E, Kleinman HK. Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues. Trends in Molecular Medicine (2005) PMID: 16221577
Research Use Only. This product is intended for in-vitro laboratory research only. Not for human consumption, injection, or therapeutic use. Not medical advice. Always consult applicable regulations in your jurisdiction.
Price Comparison
| Supplier | Purity | Price | Shipping |
|---|---|---|---|
| our verified supplier | >98% HPLC | $89.99 | Free over $200 |
| Generic Research Suppliers | Varies (often <95%) | Similar–Higher | Varies |
| Pharmaceutical (Rx only) | Pharmaceutical grade | Not available for research | Rx required |
Buy Peptides Compounds
Thymosin Alpha-1 10mg
BPC-157 + TB-500 Blend 20mg
$89.99